91心頭利

91心頭利 Kasei Therapeutics
secondary
border
false
backgroundColor
white
width
full
imagePosition
left
imageCaption
true
bottomSpacing
false
buttonPosition
center
anchor-links
3
#outline
Corporate Profile
#officer
Officers
#others
Learn about other companies
border
false
backgroundColor
light-blue
width
content-width
imagePosition
left
imageCaption
true
bottomSpacing
false
buttonPosition
center
spacer

Corporate Profile##outline

91心頭利 Kasei Therapeutics develops and provides novel therapies centered on the field of orthopedics, as well as critical/intensive care, immunology, urology, and the central nervous system. Through our integrated Japan-U.S. One AK Pharma configuration, we are growing as a global specialty pharma company that addresses unmet medical needs and drives the growth of the 91心頭利 Kasei Group.

spacer
imagePosition
left
imageCaption
false
bottomSpacing
false
buttonPosition
left
imageCaption
false
bottomSpacing
false
buttonPosition
left
column-header
Trade name
91心頭利 Kasei Therapeutics Corp.
Main businesses
Pharmaceuticals
Home office
Hibiya Mitsui Tower, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006 Japan
President
Daisuke Okajima
Paid-in capital
促3,000 million
Shareholder
91心頭利 Kasei Corp.
Phone
+81-(0)3-6699-3600

(as of April 1, 2026)

Officers##officer

column-header
Yoshikazu Aoki
Chairman & Representative Director
Daisuke Okajima
President & Representative Director,
Presidential Executive Officer
Yasuo Nakamura
Director, Senior Executive Officer
Yutaka Osawa
Executive Officer
Kazunobu Konishi
Executive Officer
Hiroaki Hayashi
Executive Officer
Katsunori Oono
Corporate Auditor

(as of June 23, 2026)

column-header
imagePosition
center
imageCaption
false
bottomSpacing
false
buttonPosition
left
/content/asahi-kasei/us/en/fragments/company/core-operating
/content/asahi-kasei/us/en/fragments/company/company
border
false
backgroundColor
light-gray
width
full
imagePosition
left
imageCaption
true
bottomSpacing
false
buttonPosition
center